🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a phase I/II study to determine the safety and efficacy of AM...
Status
Completed
Location
Washington University
Start Date
2007-07
Trial ID
NCT00512252
Treatments Being Tested
This bridging study will evaluate the efficacy of uproleselan, a specific E...
Status
Terminated
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-11-17
Trial ID
NCT05054543
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
The purpose of this study is to evaluate the addition of Sirolimus (rapamyc...
Status
Completed
Location
University of Pennsylvania
Start Date
2010-07
Trial ID
NCT01184898
Treatments Being Tested
This is a multicenter, randomized, open-label, pragmatic low intervention c...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-02-27
Trial ID
NCT06713837
Treatments Being Tested
This study aims to investigate the efficacy and safety of cladribine, combi...
Status
Recruiting
Location
The First Affliated Hospital of Soochow University
Start Date
2022-10-01
Trial ID
NCT05657639
Treatments Being Tested
This study will evaluate the safety and tolerability of uproleselan(GMI-127...
Status
Completed
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-02-24
Trial ID
NCT04839341
Treatments Being Tested
Multicenter, randomized, open-label, parallel-group study of guadecitabine ...
Status
Completed
Location
University of Southern California
Start Date
2017-03-16
Trial ID
NCT02920008
Treatments Being Tested
The purpose of this study is to evaluate the side effects of sirolimus (rap...
Status
Completed
Location
University of Pennsylvania Abramson Cancer Center
Start Date
2007-07
Trial ID
NCT00780104
Treatments Being Tested
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-11-22
Trial ID
NCT03926624